Company Filing History:
Years Active: 2015
Title: Cornelius Gauer: Innovator in Pharmaceutical Chemistry
Introduction
Cornelius Gauer is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid forms of specific compounds. His work is essential for advancing medical treatments and improving drug formulations.
Latest Patents
Gauer holds a patent for "Polymorphs of (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide." This invention relates to specific solid forms of the compound and its solvates. The patent also covers processes for preparing these solid forms, pharmaceutical compositions that include them, and methods for using these compositions to treat diseases.
Career Highlights
Cornelius Gauer is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development. Gauer's expertise in pharmaceutical chemistry has led to advancements that benefit both the industry and patients.
Collaborations
Gauer has collaborated with notable colleagues, including Isabelle Sylvie Gallou and Frank Stowasser. These collaborations have fostered a productive environment for research and innovation in pharmaceutical sciences.
Conclusion
Cornelius Gauer's contributions to pharmaceutical chemistry through his patent and work at Novartis AG highlight his role as an innovator in the field. His efforts continue to impact the development of effective medical treatments.